Most Read News

Indoco Remedies will also continue providing products to its existing B2B customers under existing deals.

Arcedo Systems will undertake the design, engineering, installation, and ongoing maintenance of the solar power facility.

Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.

On December 4, the indices closed higher amid high volatility.

Larsen & Toubro agreed to buy a 21% share in E2E Networks Ltd, a cloud services company, for ₹1,407.02 Crore.

The business also stated that its trading window has been locked since September 25 and would remain so until further notice.

Although she did not commit to a specific rate of easing, Christine Lagarde stated that the ECB will keep lowering rates.

Vodafone will clear its $101 million debt (about ₹856 Crore) and utilize the remaining cash to cover its Indian venture.

Gujarat Urja Vikas Nigam Ltd (GUVNL) has selected the company for handling part of a 500 MW/1000 MWh standalone battery energy storage initiative.

HDFC Life, HDFC Bank, Apollo Hospital, and NTPC are the major gainers in Nifty. Conversely, Cipla, Bharti Airtel, PowerGrid Corp, and Tata Motors top the list of losers in Nifty.